Business Viability Diagnosis: Metrics and Decisional Tests

Context

When a Portuguese company faces financial difficulties—such as defaulting on obligations, losing market share, or negative equity—the critical decision is not whether there are problems, but whether there is recoverable economic value. The business viability diagnosis answers a binary question with irreversible consequences: restructure or liquidate. Getting this decision wrong destroys capital in both directions: keeping a terminal company alive burns resources of creditors, employees, and the State; prematurely liquidating a recoverable company wastes productive capacity and accumulated knowledge.

This is not an academic issue. Of the 532,174 active non-financial companies in Portugal in 2024, thousands face annual solvency or liquidity crises that require rigorous going-concern assessment. The Portuguese business landscape—99.9% SMEs—shows extreme heterogeneity: family businesses with valuable assets but poor management coexist with high-growth tech startups with fragile capital structures, and with traditional industrials in mature sectors with squeezed margins. There is no simple heuristic that separates viable from terminal cases.

Superficial approaches to this decision—financial ratio checklists, rule-of-thumb guidelines on financial autonomy, analyses that ignore market dynamics—produce false positives (failed restructurings that prolong agony) and false negatives (premature liquidations of companies that could have been saved). International evidence shows that restructuring success rates vary between 30% and 70% depending on the rigor of the initial diagnosis. Portugal, with an evolving legal framework for insolvency and recovery (Código da Insolvência e da Recuperação de Empresas, CIRE), needs analytical frameworks that integrate operational, financial, and strategic dimensions in a disciplined manner.

This article isolates the methodological core of viability diagnosis: which metrics discriminate between recoverable and terminal companies, which decisional tests withstand cognitive biases of managers and creditors, and how to build a decision matrix that protects stakeholders and preserves economic value where it exists. This is not a restructuring guide—it is an analysis of the analytical instruments that precede any financial turnaround decision.

The State of the Evidence

Research on corporate distress and business viability is based on three traditions: bankruptcy prediction studies, analysis of turnaround success factors, and literature on valuation in distressed asset contexts. None provides a definitive answer, but emerging consensus points to multi-dimensional frameworks combining quantitative indicators with qualitative assessment of management capability and competitive position.

Altman (1968) established the quantitative paradigm with the Z-Score, a discriminant model combining five financial ratios (working capital/total assets, retained earnings/assets, EBIT/assets, market value of equity/liabilities, sales/assets) to predict bankruptcy up to two years in advance. Subsequent validations show 80-90% accuracy one year before bankruptcy, but performance deteriorates over longer horizons and in non-industrial sectors. A critical limitation: the model assumes continuity of historical patterns and does not capture technological disruption or structural market changes.

Slatter & Lovett (1999), in "Corporate Turnaround," analyzed 100 successful restructuring cases in the UK and identified three necessary (but not sufficient) conditions for viability: a core business with potential to generate positive cash flow, a cost structure adjustable in the short term, and management capable of executing a turnaround plan. Companies failing these three conditions had a restructuring success rate below 15%. Those meeting them achieved a five-year survival rate of 65%.

Hotchkiss (1995), in an analysis of 197 US companies emerging from Chapter 11 bankruptcy, documented that 40% re-entered financial distress within three years. Predictive factors for re-distress included: post-restructuring leverage above 60%, no management change, and sectors in structural decline. Implication: financial restructuring without correcting operational or strategic causes provides only temporary relief.

Damodaran, in "Investment Valuation" (updated annually), establishes that viability should be tested by comparing going concern value (calculated by DCF of projected cash flows) and orderly liquidation value of assets. A company is viable if and only if the going concern value exceeds the liquidation value plus restructuring costs. This approach shifts focus from historical ratios to future value generation capacity, but introduces critical dependence on projection assumptions.

Emerging consensus: robust business viability diagnosis requires three layers—(1) financial tests of solvency and liquidity, (2) operational assessment of efficiency and competitive position, (3) strategic analysis of business model sustainability. Disagreement persists over the relative weighting of these dimensions and over quantitative thresholds separating recoverable from terminal cases. Portuguese literature on the subject is scarce; applying international frameworks to the national context requires careful calibration to the specificities of the business landscape and the legal insolvency regime.

The Mechanisms

The business viability diagnosis operates through three interdependent analytical mechanisms: operational viability test (does the company have a sustainable core business?), financial viability test (is the capital structure recoverable?), and strategic viability test (is the business model still relevant?). Each mechanism isolates a distinct risk dimension; their interaction determines the final verdict.

Mechanism 1: Operational Viability Test

Operational viability measures the company’s ability to generate positive margins and sustain competitive advantage in its target market. The test is based on three pillars: competitive position, value chain efficiency, and management quality. Porter (1985) established that sustainable competitive advantage derives from cost leadership, product differentiation, or niche focus—companies without a defensible position in any of these dimensions face margin erosion and loss of market share.

Key indicators include: EBITDA margin (ability to cover fixed costs and generate operating cash flow), market share evolution (signal of competitive relevance), productivity per employee (operational efficiency), and asset turnover (capital utilization intensity). A company with recurring negative EBITDA—two or more consecutive years—faces a presumption of operational inviability, unless operating in a high-growth sector with a clear trajectory to break-even. Market share loss above 20-30% over three years signals product obsolescence or loss of competitive relevance.

Qualitative tests complement quantitative metrics: does the company retain key clients or face high churn? Do suppliers maintain commercial terms or require advance payment? Do senior staff stay or is there high talent turnover? Negative answers indicate deterioration of relational and reputational capital, intangible assets critical for recovery.

Innovation and adaptability capacity distinguishes recoverable companies from terminal cases. A company that demonstrates the ability to launch new products, enter new markets, or reposition its offering in response to demand changes shows higher operational viability than one stuck in an obsolete business model. Analysis of innovation pipeline, R&D investment (even if modest), and speed of response to market feedback provides forward-looking signals that historical ratios do not capture.

Mechanism 2: Financial Viability Test

Financial viability assesses whether the company can meet short-term obligations (liquidity) and sustain a long-term capital structure (solvency). The distinction is critical: companies can be solvent but illiquid (assets exceed liabilities, but no cash to pay suppliers), or liquid but insolvent (cash available, but liabilities structurally exceed assets). Rigorous diagnosis tests both dimensions.

Liquidity ratios include: current ratio (current assets / current liabilities, minimum threshold ~1.0), quick ratio (excluding inventories, threshold ~0.8), and cash conversion cycle (days between paying suppliers and receiving from clients). Companies with a current ratio below 1.0 for two consecutive quarters face risk of cash shortfall. A cash conversion cycle above 90 days in fast-turnover sectors signals working capital bottlenecks.

Solvency ratios include: equity ratio (equity / total assets), debt-to-equity ratio, and interest coverage (EBITDA / financial charges). The equity ratio benchmark varies by sector: PME Líder 2024 companies average 59.4%, but capital-intensive sectors (industry, logistics) operate with lower equity ratios. Negative equity (negative net worth) indicates technical insolvency, though recovery is possible if creditors accept debt-to-equity conversion.

Debt Service Coverage Ratio (DSCR)—operating cash flow available for debt service divided by principal and interest due—is a decisive metric. DSCR below 1.0 means the company does not generate enough cash to pay its debt; DSCR below 1.0 for two consecutive years signals structural, not cyclical, financial inviability. The safety threshold is DSCR ≥ 1.25, providing a buffer for adverse shocks.

Debt structure analysis complements ratios: debt concentrated among a few creditors facilitates renegotiation; dispersed debt complicates agreements. Debt secured by liquid assets (real estate, equipment) provides collateral for refinancing; unsecured debt requires conversion to equity or partial forgiveness. Debt maturity matters: maturities concentrated in the short term (next 12 months) create liquidity pressure that can force premature liquidation of an operationally viable company.

Mechanism 3: Strategic Viability Test

Strategic viability assesses whether the company’s business model remains relevant in light of market trends, technological disruption, and regulatory changes. A company can be operationally efficient and financially solvent, but doomed by strategic obsolescence—a classic case: Kodak before the digital transition. The strategic test identifies whether distress is idiosyncratic (poor management, temporary shock) or a symptom of structural industry decline.

Product/service lifecycle analysis is the starting point: does the company operate in a growing, mature, or declining market? Growing markets offer room for recovery even with temporary market share loss; structurally declining markets (demand falling >5% per year for three years) make recovery unlikely without a radical pivot. Analysis of demand trends, market price evolution, and competitor entry/exit provides forward-looking signals.

Customer concentration and dependence on critical suppliers introduce strategic risk: companies with over 50% of revenue from a single client face extreme vulnerability; losing that client can be terminal. Dependence on a single supplier for a critical input creates supply chain disruption risk. Diversification of customer base and supplier redundancy are indicators of strategic resilience.

Adaptability and pivoting capacity distinguish companies with strategic viability from those stuck in obsolete models. Companies with a track record of successful repositioning—entering new markets, launching new products, adopting new technologies—have a higher probability of executing a strategic turnaround. Organizational rigidity, resistance to change, and lack of innovation culture are qualitative red flags that financial metrics do not capture.

Sector benchmarking provides critical context: if a company underperforms peers across all dimensions (margins, growth, profitability), the problem is idiosyncratic and potentially fixable; if the entire industry faces margin compression and declining demand, the problem is structural and recovery requires sector change or exit. Analysis of market multiples of comparable transactions indicates whether buyers are willing to pay for the company’s assets—a sign of residual economic value.

The Portuguese Case

The Portuguese context for 2024-2026 presents particularities that affect business viability diagnosis. First, the structure of the business landscape: 99.9% of the 532,174 non-financial companies are SMEs, predominantly micro-enterprises (<10 employees). This atomization means many distressed companies lack sophisticated management control systems—financial information is delayed, projections are non-existent, and management accounting is absent. Rigorous diagnosis often requires reconstruction of historical data before any forward-looking analysis.

Second, sector concentration: traditional sectors (textiles, footwear, metalworking, agri-food) represent a significant share of industrial GVA but face competitive pressure from low-cost economies. Textiles and apparel, with ~500 companies and €3 billion in turnover, export two-thirds of production but compete with Asian producers with labor costs 60-70% lower. Viability in these industries requires positioning in value-added segments (design, quality, speed)—companies stuck in commodity production face structural inviability.

Third, access to financing: the Portuguese banking sector in 2024 shows solid indicators (ROE 16.1%, CET1 ratio 18%, NPL ratio 2.4%), but risk appetite for distressed companies remains limited. Companies in restructuring struggle to obtain working capital financing, even when operationally viable. Alternatives—private equity, venture debt, factoring—exist but have lower penetration than in markets like the UK or Germany. Implication: financial viability in Portugal critically depends on self-financing capacity or debt-to-equity conversion.

Fourth, legal framework: the Código da Insolvência e da Recuperação de Empresas (CIRE) offers restructuring mechanisms (Special Revitalization Process—PER, out-of-court agreements), but success rates remain modest. Court data indicate that most insolvency proceedings result in liquidation, not recovery—a reflection of late diagnoses (companies enter proceedings when already terminal) and misaligned creditor incentives. A successful PER requires a rigorous prior viability diagnosis and creditor agreement on the restructuring plan.

Fifth, macroeconomic context 2025-2026: Banco de Portugal projects GDP growth of 2.0% in 2025 and 2.3% in 2026, with controlled inflation (2.3% in 2025) and unemployment at historic lows (5.8% in Q4 2025). The ECB has begun a rate-cutting cycle—refinancing rate at 2.40% in April 2025, DFR 2.25%—easing pressure on financial charges. A favorable macroeconomic environment extends the viability window: companies with cyclical problems benefit from resilient domestic demand and falling financing costs. Companies with structural problems, however, are not saved by a benign context.

Sixth, specificity of family businesses: ~75% of the Portuguese business fabric is family-owned, often with informal governance and poorly planned succession. Family businesses in distress show a distinct pattern: valuable assets (real estate, brand, know-how) coexist with poor management and paralyzing shareholder conflicts. Viability diagnosis should separate the economic value of assets from management quality—a company may be viable with a management change or sale to third parties, even if unviable under current control. Analysis of corporate governance is a critical component in the Portuguese context.

Management Decisions

Business viability diagnosis is not an academic exercise—it is a decision-making tool that guides the allocation of capital and scarce resources. Decision-makers—managers, creditors, investors, court-appointed administrators—face three mutually exclusive options: operational and financial restructuring, sale of assets or business units, or orderly liquidation. Each option involves specific trade-offs and requires verifiable assumptions.

Option 1: operational and financial restructuring. Appropriate when diagnosis confirms operational and strategic viability, but the financial structure is unsustainable. The company has a cash-generating core business, a defensible competitive position, and management capable of executing a turnaround plan, but suffers from over-indebtedness. The typical solution combines: operational cost reduction (10-30% in severe cases), debt renegotiation with creditors (maturity extension, rate reduction, partial conversion to equity), and recapitalization (new investors or capital increase by existing shareholders). Risk: the restructuring plan relies on future cash flow projections—if assumptions fail, the company re-enters distress. Mitigation: stress testing projections with pessimistic scenarios, financial covenants that trigger early corrective action, and strengthened governance with creditor participation on the board.

Option 2: sale of assets or business units. Appropriate when the company operates multiple businesses, some viable and others terminal, or when assets have a market value higher than their going-concern value in the current owner’s hands. Divestment of non-core or underperforming units frees up capital to reinforce viable businesses; asset sales (real estate, equipment, intellectual property) reduce debt and improve solvency ratios. Critical decision: timing of sale. Forced sales (fire sales) destroy value—buyers exploit the seller’s urgency and pay discounts of 30-50% below fair value. Orderly sales, with a competitive process and proper due diligence, maximize realization value. Implication: viability diagnosis should be conducted before a terminal liquidity crisis, preserving room for an orderly sale. Analysis of financial modeling for M&A provides a framework for estimating asset realization value.

Option 3: orderly liquidation. Appropriate when diagnosis confirms operational, financial, and strategic inviability—the company has no sustainable core business, the capital structure is irrecoverable, and the business model is obsolete. Prolonging the company’s life destroys value for all stakeholders: creditors recover less the later liquidation occurs (assets depreciate, clients migrate, talent leaves), employees face prolonged uncertainty, and managers waste effort on a lost cause. Orderly liquidation maximizes realization value through open market asset sales, minimizes legal and administrative costs, and allows resource redistribution (capital, labor) to productive uses. The decision to liquidate is painful but necessary when alternatives are worse.

Common trade-offs: (1) Speed versus value—rapid restructuring minimizes distress costs but may force excessive concessions to creditors; slow processes preserve options but accumulate operating losses. (2) Control versus capital—recapitalization with external investors brings fresh capital but dilutes original shareholders; self-financing preserves control but limits resources for turnaround. (3) Transparency versus negotiation—full disclosure of problems facilitates rigorous diagnosis but may scare clients and suppliers; opacity preserves commercial relationships in the short term but prevents structural solutions.

Decisive questions managers should ask: (1) If we injected €X of new capital, would the company generate returns above the cost of capital in three years? (2) Is there a buyer willing to pay more for assets than their discounted going-concern value? (3) Would creditors accept debt-to-equity conversion or partial forgiveness, and under what conditions? (4) Does the current management team have the skills and credibility to execute a turnaround, or is a management change a precondition? (5) How much time do we have before a liquidity crisis forces a rushed decision? Honest answers to these questions, grounded in a rigorous viability diagnosis, guide the choice between restructuring, sale, or liquidation. Lack of clear answers indicates the need to deepen the diagnosis before committing resources.

Limits and Unknowns

No matter how rigorous, business viability diagnosis faces intrinsic limits. First, dependence on projections: viability relies on estimates of future cash flows, which depend on assumptions about market evolution, competitor behavior, and turnaround execution. Small changes in assumptions—sales growth rate, EBITDA margin, discount rate—produce significant variations in going-concern value. Uncertainty is irreducible; diagnosis provides probabilities, not certainties.

Second, cognitive biases: managers and shareholders tend to overestimate the probability of recovery (optimism bias) and prolong terminal companies due to emotional attachment or aversion to realized losses (sunk cost fallacy). Creditors face the opposite incentive—a preference for early liquidation to minimize exposure, even when restructuring would maximize aggregate value. Rigorous technical diagnosis mitigates but does not eliminate these biases; governance with independent stakeholder participation (non-executive directors, external experts) provides a counterbalance.

Third, contexts of rapid disruption: in sectors subject to accelerated technological change (technology, media, retail), strategic viability can evaporate within months. Diagnosis based on historical data and linear trends fails when disruption is non-linear. A company can go from viable to terminal without advance warning in financial ratios—case in point: Nokia, market leader in mobile phones, collapsed with the arrival of the iPhone. Implication: diagnosis should incorporate extreme scenario analysis and robustness tests against disruptive shocks.

Fourth, information limitations: in SMEs without sophisticated management control systems, financial data are often incomplete, delayed, or unreliable. Rigorous diagnosis requires reconstruction of historical information and validation of assumptions—a costly and time-consuming process. In acute distress situations, time is a luxury. The trade-off between analytical rigor and decision speed is inescapable.

Persistent unknowns: (1) What is the optimal quantitative threshold for DSCR, equity ratio, or EBITDA margin that separates viable from non-viable companies? Literature provides ranges, not unique values; calibration depends on sector, size, and macroeconomic context. (2) How to weigh qualitative dimensions (management quality, organizational culture, reputation) against quantitative metrics? There is no consensus algorithm. (3) To what extent is viability endogenous—a company becomes viable because stakeholders believe it is and act accordingly (self-fulfilling prophecy)? A philosophical question with practical implications: communicating the diagnosis affects the outcome. Full transparency about these limits is part of responsible diagnosis.

Next step: if this topic requires an executive decision, Macro Consulting can support with Corporate Finance, linking diagnosis, priorities, and execution.

Sources

• Altman, E. I. (1968), 'Financial Ratios, Discriminant Analysis and the Prediction of Corporate Bankruptcy', Journal of Finance, Vol. 23, No. 4, pp. 589-609. Seminal bankruptcy prediction model based on discriminant analysis of financial ratios.
• Slatter, S. & Lovett, D. (1999), 'Corporate Turnaround: Managing Companies in Distress', Penguin Books. Analysis of 100 successful restructuring cases, identifying necessary conditions for viability.
• Hotchkiss, E. S. (1995), 'Postbankruptcy Performance and Management Turnover', Journal of Finance, Vol. 50, No. 1, pp. 3-21. Empirical study of 197 US post-Chapter 11 companies, documenting a 40% re-distress rate.
• Damodaran, A., 'Investment Valuation: Tools and Techniques for Determining the Value of Any Asset', 3rd Edition, Wiley. Valuation framework applied to distressed assets, comparing going concern versus liquidation value.
• INE (2024), 'Empresas em Portugal 2024 — Dados Definitivos', Instituto Nacional de Estatística. Official statistics on the Portuguese business landscape, including breakdown by size and sector.
• IAPMEI (2024), 'PME Líder 2024 — Estatuto e Critérios', IAPMEI — Agência para a Competitividade e Inovação. Data on 13,394 top-performing SMEs, including average equity ratio of 59.4%.
• Banco de Portugal (2025), 'Boletim Económico Dezembro 2025', Banco de Portugal. Macroeconomic projections for Portugal 2025-2028, including GDP growth and interest rate trends.
• Porter, M. E. (1985), 'Competitive Advantage: Creating and Sustaining Superior Performance', Free Press. Seminal work on competitive advantage and value chain, foundation for operational viability analysis.
• Kaplan, R. S. & Norton, D. P. (1992), 'The Balanced Scorecard: Measures That Drive Performance', Harvard Business Review, Jan-Feb 1992. Multi-dimensional performance assessment framework, applicable to viability diagnosis.
• CMVM, 'Código da Insolvência e da Recuperação de Empresas (CIRE)', Decreto-Lei n.º 53/2004, with subsequent amendments. Portuguese legal framework for insolvency and restructuring proceedings.